Evidence map›Paper›PMID 38543034›Full record

ArticleMolecules (Basel, Switzerland)2024

Hybrid Peptide-Alkoxyamine Drugs: A Strategy for the Development of a New Family of Antiplasmodial Drugs.

Ange W Embo-Ibouanga, Michel Nguyen, Lucie Paloque, Mathilde Coustets, Jean-Patrick Joly, Jean-Michel Augereau, Nicolas Vanthuyne, Raphaël Bikanga, Naomie Coquin, Anne Robert and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Ange W Embo-IbouangaAix-Marseille University, CNRS, UMR 7273, 13007 Marseille, France.
Michel NguyenLCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.
Lucie PaloqueLCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.ORCID 0000-0003-0359-3959
Mathilde CoustetsLCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.
Jean-Patrick JolyAix-Marseille University, CNRS, UMR 7273, 13007 Marseille, France.ORCID 0000-0002-4844-7499
Jean-Michel AugereauLCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.ORCID 0000-0002-2847-1969
Nicolas VanthuyneAix-Marseille University, CNRS, Centrale Marseille ISM2 Marseille, 13007 Marseille, France.ORCID 0000-0003-2598-7940
Raphaël BikangaUniversité des Sciences et Techniques de Masuku, LASNSOM, BP 901 Franceville, Gabon.
Naomie CoquinLCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.
Anne RobertLCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.ORCID 0000-0002-9092-6776
Gérard AudranAix-Marseille University, CNRS, UMR 7273, 13007 Marseille, France.
Jérôme BoissierIHPE, University Montpellier, CNRS, Ifremer, University Perpignan Via Domitia, 66860 Perpignan, France.ORCID 0000-0002-0793-3108
Philippe MelletMagnetic Resonance of Biological Systems, UMR 5536 CNRS-University of Bordeaux, 33076 Bordeaux, France.
Françoise Benoit-VicalLCC-CNRS, Laboratoire de Chimie de Coordination and MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Université de Toulouse, CNRS, 31077 Toulouse, France.ORCID 0000-0002-9468-4823
Sylvain R A MarqueAix-Marseille University, CNRS, UMR 7273, 13007 Marseille, France.
Centre National de la Recherche Scientifique · FRUniversité des Sciences et Techniques de Masuku · GA

Funding

Agence Nationale de la Recherche ANR-17-CE18-0017Fondation pour la Recherche Médicale Équipe FRM EQU202103012596
6 · The paper itself

Abstract

The emergence and spread of drug-resistant

Indexed as

AntimalarialsCytostatic AgentsMalariaMalaria, FalciparumHumansPeptidesPlasmodium falciparumAntimalarialsCytostatic AgentsPeptidesalkoxyaminedrug resistancemalariaPlasmodiumprodrug

Identifiers

PMID38543034
PMCPMC10974622
OpenAlexW4393055106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.